COVID-19: ICU delirium management during SARS-CoV-2 pandemic-pharmacological considerations
- PMID: 32576234
- PMCID: PMC7309692
- DOI: 10.1186/s13054-020-03072-5
COVID-19: ICU delirium management during SARS-CoV-2 pandemic-pharmacological considerations
Conflict of interest statement
Not applicable
Comment on
-
COVID-19: ICU delirium management during SARS-CoV-2 pandemic.Crit Care. 2020 Apr 28;24(1):176. doi: 10.1186/s13054-020-02882-x. Crit Care. 2020. PMID: 32345343 Free PMC article. Review.
References
-
- Garber PM, Droege CA, Carter KE, Harger NJ, Mueller EW. Continuous infusion ketamine for adjunctive analgosedation in mechanically ventilated, critically ill patients. Pharmacotherapy. 2019;39(3):288–96. 10.1002/phar.2223. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous